Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - bisoprolol fumarate, quantity: 7.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; calcium hydrogen phosphate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - bisoprolol fumarate, quantity: 1.25 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; calcium hydrogen phosphate; microcrystalline cellulose; crospovidone; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - bisoprolol fumarate, quantity: 3.75 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: polysorbate 80; magnesium stearate; hypromellose; crospovidone; citric acid monohydrate; microcrystalline cellulose; titanium dioxide; macrogol 400; povidone - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: hypromellose; macrogol 400; povidone; microcrystalline cellulose; crospovidone; citric acid monohydrate; polysorbate 80; titanium dioxide; magnesium stearate - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - quetiapine fumarate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - quetiapine fumarate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - quetiapine fumarate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - quetiapine fumarate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 6 mg - tablet, film coated - excipient ingredients: quinoline yellow; maize starch; lactose monohydrate; hypromellose; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.